510(k) device
Biomonitor IV (471155)
Biotronik, Inc. · Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD, Class II) · First FDA decision May 19, 2023, newest May 1, 2026Atrial fibrillation
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "Biomonitor IV"
MAUDE reports
112
Brand "Biomonitor IV", since 2015
PubMed studies
0
Mentioning "Biomonitor IV"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Biomonitor IV (471155)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- BIOMONITOR IV (471155)510(k)
K261074 · Decided May 1, 2026 · 30 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Biomonitor IV", any status and sponsor, newest update first.
Biotronik SE & Co. KGNot on our public-company list
NCT06989580 · 300 participants (planned) · Start Aug 22, 2025 · Primary completion Dec 31, 2028
Device: BIOMONITOR IV with study software · For: Heart Failure; Arrhythmia; Decompensated Heart Failure and 1 more
Sites: Genk, Belgium; Munich, Germany
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Biomonitor IV", and for the whole product code for context.
This brand
112 reports: 11 malfunction, 101 injury, 0 death
Whole product code MXD
13,376 reports: 11,084 malfunction, 2,288 injury, 3 death
Newest reports for this brand
- BIOMONITOR IVInjury
1028232-2026-05008 · Received Oct 26, 2026 · Event dated Oct 22, 2026
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: Wound Dehiscence
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Biomonitor IV"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MXD.
- LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)Medtronic, Inc. · 510(k) 2026
- Reveal LINQ Insertable Cardiac MonitorMedtronic, Inc. · 510(k) 2023
- Reveal LINQMedtronic, Inc. · 510(k) 2017
- BioMonitor 2-AF, BioMonitor 2-S, FIT - Fast Insert Tool 1 + 2, SetBiotronik, Inc. · 510(k) 2017
- LUX-Dx Insertable Cardiac MonitorBoston Scientific Corporation · 510(k) 2021
- Biomonitor III, Biomonitor IIImBiotronik, Inc. · 510(k) 2020
- BioMonitorBiotronik, Inc. · 510(k) 2015
- Assert-IQ (DM5100)Abbott Medical · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.